Midterm Outcomes of Pharmacomechanical Thrombectomy in the Treatment of Lower Extremity Deep Vein Thrombosis With a Rotational Thrombectomy Device

Vascular and Endovascular Surgery
Ahmet Yüksel, Oktay Tüydeş

Abstract

The purpose of this study was to assess the safety and efficacy with midterm outcomes of pharmacomechanical thrombectomy (PMT) performed by using a relatively new thrombectomy device in the treatment of lower extremity deep vein thrombosis (DVT). Between February 2014 and February 2016, a total of 46 patients with lower extremity DVT were treated with PMT by using Cleaner rotational thrombectomy system. Preprocedural, intraprocedural, postprocedural, and follow-up records of patients were collected and retrospectively analyzed. Mean age of patients was 50.5 (14.8) years, and 58.7% of them were female. Technical success rate of procedure was 91.3%. Mean procedure time was 81.8 (40.3) minutes. Early clinical improvement was observed in all patients with successful treatment. No serious adverse event related to procedure and mortality was observed. Mean follow-up time was 16.0 (7.9) months. Reocclusion was observed in 7 (17.5%) patients during the follow-up period. Venous patency rates of patients at 1-, 3-, 6-, and 12-month follow-up visits were 95%, 92.5%, 89.7%, and 79.5%, respectively. Mild, moderate, and severe postthrombotic syndrome were observed in 8 (20%) patients, 4 (10%) patients, and 1 (2.5%) patient, respectively. Pos...Continue Reading

References

Apr 12, 2003·Journal of Vascular and Interventional Radiology : JVIR·Melhem J SharafuddinByung-Suk Roh
Oct 9, 2008·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Tilo KölbelAnders Gottsäter
Nov 20, 2008·Annals of Internal Medicine·Susan R KahnJeffrey S Ginsberg
Feb 19, 2009·Journal of Thrombosis and Thrombolysis·Aneel A Ashrani, John A Heit
Jul 30, 2009·Pharmacotherapy·Paul P Dobesh
Feb 4, 2011·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·A KarthikesalingamP J E Holt
Mar 23, 2011·Circulation·Michael R JaffUNKNOWN American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology
Mar 24, 2012·Journal of Vascular Surgery·Edward T CaseyMark Meissner
Oct 6, 2014·Journal of Vascular and Interventional Radiology : JVIR·Cüneyt KöksoyUmman N Sanlıdilek
May 31, 2015·Journal of Vascular Nursing : Official Publication of the Society for Peripheral Vascular Nursing·Kathleen Rich
Jul 8, 2015·Journal of Thrombosis and Haemostasis : JTH·S Vedantham
Jan 5, 2016·The Heart Surgery Forum·Mehmet EzelsoyMuhammed Bayram
Jan 29, 2016·Expert Review of Cardiovascular Therapy·Stuart Blackwood, Alan M Dietzek
Jan 1, 2013·Journal of Vascular Surgery. Venous and Lymphatic Disorders·Gregory A StanleyFrank R Arko

❮ Previous
Next ❯

Citations

Feb 28, 2019·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Tao TangYongming Lu
Jun 3, 2021·São Paulo Medical Journal = Revista Paulista De Medicina·Ufuk Turan Kursat KorkmazKemalettin Erdem

❮ Previous
Next ❯

Software Mentioned

AngioJet
Statistical Package for Social Sciences ( SPSS )

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.